The global ventricular hypertrophy treatment market size is projected to rise considerably in the coming years. This growth can be attributed to a combination of factors, including an aging population, rising prevalence of cardiovascular diseases, and advancements in medical interventions. The is fueled by a need for effective treatments for ventr